NCT04026945View on ClinicalTrials.gov

Sustained Release Lidocaine for Treatment of Scrotal Pain

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

October 31, 2019

Primary Completion Date

March 24, 2021

Study Completion Date

March 24, 2021

Conditions
Chronic Pain
Interventions
DRUG

Lidocaine

Sustained-release lidocaine injection

Trial Locations (1)

V5Z 1M9

Department of Urologic Sciences, Gordon & Leslie Diamond Health Care Centre, Vancouver

All Listed Sponsors
lead

University of British Columbia

OTHER

NCT04026945 - Sustained Release Lidocaine for Treatment of Scrotal Pain | Biotech Hunter | Biotech Hunter